Medicare would cover skin substitute products and fight overbilling from top providers.
This bill would make sure Medicare Part B clearly covers skin substitute products, which are used for wound care, starting January 1, 2026. It would also set up a new, standardized way for Medicare to pay for these products. To prevent fraud, the bill would identify providers who bill the most for these products and put extra checks on their claims.
Currently, skin substitute products are not explicitly listed as covered items under Medicare Part B, and their payment is not subject to a specific, volume-weighted average method or dedicated program integrity measures. This bill would explicitly include skin substitute products as covered items under Medicare Part B, establish a new payment method for them starting January 1, 2026, and implement new measures to identify and scrutinize providers who bill the most for these products.
HR 5768 · 119th Congress · October 17, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
27 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.